Page last updated: 2024-11-10

thymidine glycol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

thymidine glycol: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3035041
CHEBI ID174638
SCHEMBL ID16240028
MeSH IDM0093739

Synonyms (12)

Synonym
5,6-dihydroxy-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,3-diazinane-2,4-dione
32645-65-1
CHEBI:174638
thymidine, 5,6-dihydro-5,6-dihydroxy-
thd glycol
5,6-dihydroxy-5,6-dihydrothymidine
hydrouracil, 1-(2-deoxy-beta-d-erythro-pentofuranosyl)-5,6-dihydroxy-5-methyl-
thymidine glycol
4,5,6-trihydroxy-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,5,6-tetrahydropyrimidin-2-one
SCHEMBL16240028
DTXSID80954355
1-(2-deoxypentofuranosyl)-4,5,6-trihydroxy-5-methyl-5,6-dihydropyrimidin-2(1h)-one

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" We have constructed a dose-response curve for formation of each isomer in gamma-irradiated DNA and shown that they are formed in equal amounts."( Quantitative measurement of the diastereoisomers of cis thymidine glycol in gamma-irradiated DNA.
Cadet, J; Cummings, A; Frenkel, K; Shaw, A; Teebor, G; Voituriez, L, 1987
)
0.52
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
pyrimidine 2'-deoxyribonucleoside
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (41)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (29.27)18.7374
1990's9 (21.95)18.2507
2000's11 (26.83)29.6817
2010's7 (17.07)24.3611
2020's2 (4.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.01 (24.57)
Research Supply Index3.78 (2.92)
Research Growth Index4.50 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.38%)5.53%
Reviews3 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (2.38%)0.25%
Other37 (88.10%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]